Georgeta Fried

3.8k total citations · 1 hit paper
38 papers, 2.1k citations indexed

About

Georgeta Fried is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Genetics. According to data from OpenAlex, Georgeta Fried has authored 38 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Oncology, 16 papers in Pulmonary and Respiratory Medicine and 13 papers in Genetics. Recurrent topics in Georgeta Fried's work include BRCA gene mutations in cancer (12 papers), Breast Cancer Treatment Studies (11 papers) and Advanced Breast Cancer Therapies (9 papers). Georgeta Fried is often cited by papers focused on BRCA gene mutations in cancer (12 papers), Breast Cancer Treatment Studies (11 papers) and Advanced Breast Cancer Therapies (9 papers). Georgeta Fried collaborates with scholars based in Israel, United States and United Kingdom. Georgeta Fried's co-authors include Bella Kaufman, Ora Rosengarten, Salomon M. Stemmer, Judith Balmañà, Gillian Mitchell, Michael Friedländer, Susan M. Domchek, Ronnie Shapira‐Frommer, M. William Audeh and Ayala Hubert and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Cancer Research.

In The Last Decade

Georgeta Fried

37 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Olaparib Monotherapy in Patients With Advanced Cancer and a Germline BRCA1/2 Mutation

2014 1.2k citations Bella Kaufman, Georgeta Fried et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Georgeta Fried Israel	17	1.6k	702	539	502	432	38	2.1k
Mariana Steiner Israel	18	1.3k 0.8×	614 0.9×	399 0.7×	339 0.7×	369 0.9×	31	1.9k
Nina Ditsch Germany	24	555 0.3×	513 0.7×	310 0.6×	485 1.0×	202 0.5×	116	1.8k
Dirk Bauerschlag Germany	25	641 0.4×	1.1k 1.6×	462 0.9×	239 0.5×	355 0.8×	121	2.4k
Marcus Q. Bernardini Canada	30	834 0.5×	723 1.0×	496 0.9×	225 0.4×	1.3k 3.1×	134	3.1k
Daniel Egle Austria	18	1.0k 0.6×	990 1.4×	613 1.1×	211 0.4×	106 0.2×	88	2.3k
Rowan Miller United Kingdom	16	953 0.6×	820 1.2×	239 0.4×	171 0.3×	524 1.2×	77	1.6k
Anna Måsbäck Sweden	22	844 0.5×	423 0.6×	362 0.7×	187 0.4×	397 0.9×	48	1.8k
B A Ponder United Kingdom	25	745 0.5×	1.1k 1.5×	483 0.9×	1.3k 2.6×	413 1.0×	39	2.7k
Adam N. Rosenthal United Kingdom	24	501 0.3×	594 0.8×	320 0.6×	519 1.0×	1.0k 2.3×	69	2.3k
Angela George United Kingdom	17	564 0.3×	412 0.6×	307 0.6×	596 1.2×	331 0.8×	60	1.2k

Countries citing papers authored by Georgeta Fried

Since Specialization

Citations

This map shows the geographic impact of Georgeta Fried's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Georgeta Fried with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Georgeta Fried more than expected).

Fields of papers citing papers by Georgeta Fried

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Georgeta Fried. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Georgeta Fried. The network helps show where Georgeta Fried may publish in the future.

Co-authorship network of co-authors of Georgeta Fried

This figure shows the co-authorship network connecting the top 25 collaborators of Georgeta Fried. A scholar is included among the top collaborators of Georgeta Fried based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Georgeta Fried. Georgeta Fried is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cohen, Miri, Inbar Levkovich, Rina Katz, Georgeta Fried, & Shimon Pollack. (2020). Low physical activity, fatigue and depression in breast cancer survivors: Moderation by levels of IL-6 and IL-8. International Journal of Psychophysiology. 158. 96–102. 20 indexed citations

Denys, Hannelore, Marc Martens, Randal D’hondt, et al.. (2020). Safety and tolerability of subcutaneous trastuzumab at home administration, results of the phase IIIb open-label BELIS study in HER2-positive early breast cancer. Breast Cancer Research and Treatment. 181(1). 97–105. 26 indexed citations

Stemmer, Salomon M., Mariana Steiner, Shulamith Rizel, et al.. (2019). Ten-year clinical outcomes in N0 ER+ breast cancer patients with Recurrence Score-guided therapy. npj Breast Cancer. 5(1). 41–41. 23 indexed citations

Levkovich, Inbar, et al.. (2018). Symptom cluster of emotional distress, fatigue and cognitive difficulties among young and older breast cancer survivors: The mediating role of subjective stress. Journal of Geriatric Oncology. 9(5). 469–475. 53 indexed citations

Evron, Ella, Georgeta Fried, Bella Kaufman, et al.. (2018). Prophylactic irradiation to the contralateral breast for BRCA mutation carriers with early-stage breast cancer. Annals of Oncology. 30(3). 412–417. 36 indexed citations

Shachar, Shlomit Strulov, Tanya Mashiach, Georgeta Fried, et al.. (2017). Biopsy of breast cancer metastases: patient characteristics and survival. BMC Cancer. 17(1). 7–7. 12 indexed citations

Stemmer, Salomon M., Shulamith Rizel, David Geffen, et al.. (2017). Clinical outcomes in ER+ HER2 -node-positive breast cancer patients who were treated according to the Recurrence Score results: evidence from a large prospectively designed registry. npj Breast Cancer. 3(1). 32–32. 68 indexed citations

Passhak, Maria, Shlomit Strulov Shachar, Gil Bar‐Sela, & Georgeta Fried. (2017). Breast cancer in young women aged 35 and under: Patterns of care and outcome. The Breast Journal. 24(3). 441–443. 6 indexed citations

Stemmer, Salomon M., Shulamit Rizel, Tamar Peretz, et al.. (2016). First prospectively-designed outcome study in estrogen receptor (ER)+ breast cancer (BC) patients (pts) with N1mi or 1-3 positive nodes in whom treatment decisions in clinical practice incorporated the 21-gene recurrence score (RS) result. Annals of Oncology. 27. vi44–vi44. 3 indexed citations

10.

Rennert, Gad, Mila Pinchev, Naomi Gronich, et al.. (2016). Oral Bisphosphonates and Improved Survival of Breast Cancer. Clinical Cancer Research. 23(7). 1684–1689. 29 indexed citations

11.

Abikhzer, Gad, Georgeta Fried, Karen Drumea, et al.. (2016). Prospective comparison of whole-body bone SPECT and sodium 18F-fluoride PET in the detection of bone metastases from breast cancer. Nuclear Medicine Communications. 37(11). 1160–1168. 22 indexed citations

12.

Asleh, Karama & Georgeta Fried. (2015). Clinical and molecular characteristics of triple-negative breast cancer patients in Northern Israel: single center experience. SpringerPlus. 4(1). 132–132. 5 indexed citations

13.

Moskovitz, Mor, et al.. (2015). Post-irradiation angiosarcoma of the breast: clinical presentation and outcome in a series of six cases. Breast Cancer Research and Treatment. 153(1). 3–8. 15 indexed citations

14.

Grenader, Tal, Rinat Yerushalmi, Georgeta Fried, et al.. (2014). The 21-Gene Recurrence Score Assay (Oncotype DX™) in Estrogen Receptor-Positive Male Breast Cancer: Experience in an Israeli Cohort. Oncology. 87(1). 1–6. 26 indexed citations

15.

Dagan, Efrat, Ruth Gershoni‐Baruch, Alina Kurolap, Yael Goldberg, & Georgeta Fried. (2014). “I Do Not Want My Baby to Suffer as I Did”; Prenatal and Preimplantation Genetic Diagnosis for BRCA1/2 Mutations: A Case Report and Genetic Counseling Considerations. Genetic Testing and Molecular Biomarkers. 18(7). 461–466. 3 indexed citations

16.

Fried, Georgeta & Mor Moskovitz. (2014). Treatment decisions in estrogen receptor-positive early breast cancer patients with intermediate oncotype DX recurrence score results. SpringerPlus. 3(1). 71–71. 18 indexed citations

17.

Levkovich, Inbar, Miri Cohen, Shimon Pollack, Karen Drumea, & Georgeta Fried. (2014). Cancer-related fatigue and depression in breast cancer patients postchemotherapy: Different associations with optimism and stress appraisals. Palliative & Supportive Care. 13(5). 1141–1151. 31 indexed citations

18.

Brenner, Baruch, Georgeta Fried, Erica Rakowsky, et al.. (2002). Male breast carcinoma in Israel. Cancer. 94(8). 2128–2133. 11 indexed citations

19.

Gershoni‐Baruch, Ruth, et al.. (2000). Significantly lower rates of BRCA1/BRCA2 founder mutations in Ashkenazi women with sporadic compared with familial early onset breast cancer. European Journal of Cancer. 36(8). 983–986. 19 indexed citations

20.

Gilbar, Ohad, et al.. (1997). Living with mastectomy and breast conservation treatment: who suffers more?. Supportive Care in Cancer. 5(4). 322–326. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact